Paulson Richard A. bought KPTI
February 5, 2026 · Form 4 insider transaction
Paulson Richard A. bought 81,060 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
81,060
Price
$0.00
Total value
N/A
InsiderPaulson Richard A.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 5, 2026
Filing dateFebruary 9, 2026
Shares owned after279,391
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on January 31, 2027, with the remaining 50% vesting on January 31, 2028.